Here, we present our experience from a large, multi-centre, international cross-sectional study incorporating PD patients negative (idiopathic PD-iPD) or positive for GBA1 variants (GBA1-PD), the latter group being representative of all variant types (risk, mild, and severe). This evidence concerns the gene GBA1 and Parkinson disease.